COMMUNIQUÉS West-GlobeNewswire

Supporting Women’s Health Can Unlock Workforce Potential. Here’s What Employers and Allies Can Do
14/04/2026
Vital Talks panel discussion will explore how better support for women’s health can drive workforce participation, financial security, and economic growth TORONTO, April 14, 2026 (GLOBE NEWSWIRE) -- Women’s Health [...]
Advanced Radiation Centers of New York Launches SoftRay™ Therapy, Offering New Non-Surgical Relief of Inflammatory, Tendon and Arthritis Pain
14/04/2026
A European standard now offering New Yorkers a non-invasive alternative to chronic arthritis medications and surgery New York, NY, April 14, 2026 (GLOBE NEWSWIRE) -- Advanced Radiation Centers of New York (ARC) has [...]
HiberCell to Present Preclinical Data Demonstrating the Enhanced Antitumor Activity of HC-7366 in Combination with VEGFR-TKIs in Clear Cell Renal Cell Carcinoma (ccRCC)
14/04/2026
ROSEVILLE, Minn., April 14, 2026 (GLOBE NEWSWIRE) -- HiberCell, Inc., a clinical-stage biotechnology company developing therapeutics to address cancer relapse, metastasis, and resistance, today announced the preclinical [...]
Providence Saint John’s Health Center Announces Largest Philanthropic Gift in Its History Through Transformative Stan Lucas Legacy
14/04/2026
Estate gift estimated at $100 million will advance prostate cancer research at the Santa Monica health center SANTA MONICA, Calif., April 14, 2026 (GLOBE NEWSWIRE) -- Providence Saint John’s Health Center announced the [...]
Vietnam Shocks the World With Animal-To-Human Organ Transplantation Technology
14/04/2026
HANOI, Vietnam, April 14, 2026 (GLOBE NEWSWIRE) -- On the morning of April 4, 2026, at 10:00 AM in Hanoi, a scientific and technological bombshell was unveiled at the Meliá Hotel conference hall: the transplantation of [...]
Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations
14/04/2026
Press release – No. 7 / 2026  Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations Bringing significant experience from Vertex Pharmaceuticals and Shire Copenhagen, Denmark and Boston, [...]
Major Shareholder Announcement
14/04/2026
Company Announcement Major shareholder announcement for Genmab A/S COPENHAGEN, Denmark; April 14, 2026 – Genmab A/S (Nasdaq: GMAB) announces under reference to Section 30 of the Danish Capital Markets Act that Orbis [...]
Award-winning Medical Alert System Bay Alarm Medical Launches 'Caregiver SOS' YouTube Series to Support Family Caregivers
14/04/2026
New video series aims to provide emotional support and practical advice for caregivers nationwide. Concord, CALIFORNIA, April 14, 2026 (GLOBE NEWSWIRE) -- Bay Alarm Medical , a leader in medical alert systems, has [...]
Comprehensive Healthcare Launches “Just In Time” Prescriber Scheduling to Improve Access to Behavioral Health Medication Services
14/04/2026
New model helps clients schedule prescriber appointments within days YAKIMA, Wash., April 14, 2026 (GLOBE NEWSWIRE) -- Comprehensive Healthcare today announced the organization-wide launch of “Just In Time” prescriber [...]
AscellaHealth Inaugurates Strategic Advisory Council, With Founding Members, Advances Pharmacy Benefits Ecosystem Through Technology Deployment and Specialty Expertise
14/04/2026
BERWYN, Pa., April 14, 2026 (GLOBE NEWSWIRE) -- AscellaHealth , a global partner delivering customizable solutions to support the specialty pharmaceutical industry, today announced the formation of its Strategic [...]
Sanofi: Information concerning the total number of voting rights and shares - March 2026
14/04/2026
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
Sanofi: Informations relatives au nombre de droits de vote et d'actions - MARS 2026
14/04/2026
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]
OSE Immunotherapeutics fait évoluer son équipe de direction
14/04/2026
OSE Immunotherapeutics fait évoluer son équipe de direction Thomas Gidoin et Aurore Morello nommés respectivement Directeur Général Adjoint et Directrice Scientifique Nantes, France, 14 avril 2026 – 18h00 CEST – OSE [...]
Van Nuys' Premier Rehabilitation Center, Injury Docs, Celebrates 10,000th Patient
14/04/2026
Milestone highlights rapid growth and patient-centered approach since the clinic’s founding in 2024 Van Nuys, CA, April 14, 2026 (GLOBE NEWSWIRE) -- Injury Docs , a physical therapy and rehabilitation center based in [...]
OSE Immunotherapeutics Evolves its Leadership Team
14/04/2026
OSE Immunotherapeutics Evolves its Leadership Team Thomas Gidoin and Aurore Morello appointed Deputy CEO and CSO, respectively Nantes, France, April 14, 2026 – 6:00pm CEST - OSE Immunotherapeutics SA (ISIN: FR0012127173 [...]
Clairity Announces Update to NCCN Guidelines to Include AI Mammogram-Based Risk Tool to Identify Future Breast Cancer Risk in Women Missed by Traditional Methods
14/04/2026
Major paradigm shift incorporates five-year risk assessment and identifies increased-risk women beginning at age 35 BOSTON, April 14, 2026 (GLOBE NEWSWIRE) -- Clairity, Inc. announces the National Comprehensive Cancer [...]
Prenetics’ IM8 Health Partners with Vitamin Angels to Combat Global Malnutrition, Commits to Impacting 400,000 Mothers and Children in Year One
14/04/2026
Partnership Extends IM8’s Mission Beyond Premium Nutrition to Address Malnutrition Among the World’s Most Vulnerable Populations Long-Term Goal to Impact Millions of Lives Through Sustained Funding and Awareness Vitamin [...]
Aclarion Receives Pinnacle Award for AI Innovation
14/04/2026
Recognition Follows 2025 HLTH Digital Health Award for Nociscan Award Winning AI Targets a Large and Costly Chronic Low Back Pain Market BROOMFIELD, Colo., April 14, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc ., (“Aclarion [...]
Er-Kim Signs Exclusive Distribution Agreement with LEO Pharma A/S to Commercialize LOQTORZI® (toripalimab) for Nasopharyngeal and Oesophageal Cancers
14/04/2026
Er-Kim announces exclusive partnership with LEO Pharma A/S to launch LOQTORZI® across Central and Eastern Europe, expanding access to innovative cancer treatment for Nasopharyngeal and Oesophageal Cancers ISTANBUL and [...]

Pages